+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rheumatoid Arthritis Diagnosis Tests Market - Global Forecast to 2030- Product Image
Rheumatoid Arthritis Diagnosis Tests Market - Global Forecast to 2030- Product Image
Sale

Rheumatoid Arthritis Diagnosis Tests Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012404
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Rheumatoid Arthritis Diagnosis Tests Market grew from USD 3.08 billion in 2024 to USD 3.23 billion in 2025. It is expected to continue growing at a CAGR of 4.91%, reaching USD 4.11 billion by 2030.

Rheumatoid arthritis (RA) represents a complex autoimmune disorder characterized by chronic joint inflammation, progressive tissue damage, and systemic complications that significantly impact patient quality of life. Accurate, timely diagnosis is essential to initiating disease-modifying therapies that can slow progression and preserve function. This executive summary synthesizes the diagnostic landscape by examining conventional blood markers, advanced imaging modalities, and structured physical assessments. It highlights the interplay between technological innovation, regulatory dynamics, and evolving clinical pathways. Stakeholders require a nuanced understanding of test performance metrics, end-user adoption patterns, and cost drivers to optimize diagnostic algorithms and ensure equitable access. By integrating insights from tariff shifts, segmentation analysis, regional variances, and corporate strategies, this report equips decision-makers with a holistic perspective on the forces shaping RA diagnosis. Ultimately, bridging clinical needs with market realities will support the development of robust diagnostic frameworks that improve patient outcomes and foster sustainable growth within the RA diagnostics ecosystem.

Transformative Shifts Reshaping Rheumatoid Arthritis Diagnosis

Over the last decade, the RA diagnostic environment has undergone profound transformation driven by advances in automation, artificial intelligence, and digital health integration. Machine-learning algorithms now enhance the accuracy of imaging-based assessments by identifying subtle synovial changes on ultrasound or MRI scans. Automation in high-throughput blood analyzers has accelerated turnaround times for anti-CCP, CRP, ESR, and rheumatoid factor assays, enabling earlier disease detection. Telemedicine platforms facilitate remote joint examinations, while connected point-of-care testing devices deliver real-time biomarker results at community clinics. Furthermore, the convergence of cloud computing with secure data repositories is enabling multicenter research collaborations that refine diagnostic thresholds and validate novel biomarker panels. These shifts are not merely incremental; they redefine clinical workflows, empower multidisciplinary care teams, and elevate patient engagement through mobile monitoring tools. As regulatory bodies adapt guidelines to accommodate digital diagnostics, industry leaders must anticipate interoperability challenges and ensure compliance. This section dissects these transformative drivers and their implications for test developers, healthcare providers, and payers across the RA diagnosis continuum.

Cumulative Impact of United States Tariffs in 2025

In 2025, the implementation of new United States tariffs targeting imported diagnostic equipment and reagents has reverberated across the RA diagnostics supply chain. Manufacturers confronted elevated import duties on high-precision imaging components, immunoassay reagents, and specialized testing kits. These cost pressures have prompted strategic reassessments: some suppliers relocated production facilities to tariff-exempt regions, while others renegotiated contracts to leverage local manufacturing partnerships. Hospitals and diagnostic laboratories experienced margin compression, leading to careful prioritization of test panels and selective adoption of premium imaging services. Laboratory directors have responded by diversifying sourcing strategies, exploring regional reagent distributors, and optimizing batch testing schedules to mitigate per-unit expenses. On the reimbursement front, payers are negotiating new fee schedules that reflect tariff-driven cost inflation, altering coverage decisions for advanced diagnostics. Competitive dynamics have intensified as domestic device producers promote tariff-insulated alternatives, whereas global innovators highlight evidence of enhanced diagnostic yield. This evolving tariff landscape underscores the necessity for agile supply chain management and cross-border collaboration to sustain diagnostic accuracy without compromising cost efficiency.

Comprehensive Segmentation Insights Driving Diagnostic Strategies

A granular segmentation framework reveals critical pathways shaping diagnostic adoption and investment priorities. By test type, the market encompasses comprehensive blood panels, including anti-CCP, CRP, ESR, and rheumatoid factor assays, alongside sophisticated imaging protocols such as MRI, ultrasound, and X-ray, complemented by structured physical evaluations focused on joint flexibility and swelling metrics. This spectrum addresses clinicians’ needs for both molecular sensitivity and morphological insights. End-user analysis differentiates diagnostic operations in hospital-based and independent laboratories, alongside service models within private and public hospitals, and research settings spanning academic institutes and biotechnology entities. From a technology vantage, legacy point-of-care devices and standard computing measurement platforms coexist with cutting-edge automation solutions integrated with AI-driven analytics. Age-related diagnostic paradigms distinguish adult cohorts aged 18 to 70 in three subgroups from pediatric presentations under 18, tailoring sensitivity thresholds and sampling protocols. Test kit design further bifurcates into rapid multi-use and single-use formats, as well as home-based self-test platforms that empower patient-centered monitoring. Application segments allocate resources between initial clinical diagnosis, routine follow-up assessments, and R&D endeavors encompassing clinical trials and novel biomarker exploration. Finally, assay architecture contrasts multiplex panels targeting multiple biomarkers against single analyte tests optimized for high specificity.

Key Regional Insights Highlighting Market Variations

Regional dynamics underscore diverse drivers and adoption curves across the Americas, Europe, Middle East & Africa, and Asia-Pacific markets. In the Americas, robust healthcare infrastructure, advanced reimbursement frameworks, and high patient awareness support widespread deployment of both standard blood assays and innovative imaging techniques. Collaborative networks among academic centers accelerate validation of novel biomarkers. In Europe, Middle East & Africa, heterogeneous regulatory environments and variable payer systems challenge cross-border standardization but also stimulate localized innovation hubs, particularly within EU member states that harmonize diagnostic guidelines. Emerging economies in the region leverage public-private partnerships to expand access to essential diagnostics. In Asia-Pacific, rapid urbanization and expanding public health initiatives fuel demand for scalable point-of-care testing devices and cost-effective self-test kits. Governments are investing in digital health platforms that integrate diagnostic data with national electronic health records, enabling population-level disease surveillance. Supply chain resilience initiatives and regional manufacturing clusters mitigate import dependencies, fostering long-term market stability.

Leading Company Profiles and Strategic Imperatives

A competitive landscape analysis identifies both global leaders and niche innovators driving diagnostic excellence. Abbott Laboratories continues to expand its immunoassay portfolio with user-friendly platforms, while Beckman Coulter, Inc. enhances automation capabilities to streamline high-volume workflows. Thermo Fisher Scientific, Inc. and QIAGEN GmbH invest heavily in molecular biomarker research, targeting next-generation CRP and anti-CCP assays with improved sensitivity. Siemens Healthineers leverages its imaging expertise to integrate AI-powered ultrasound and MRI diagnostics, whereas Roche’s immunodiagnostics segment pioneers multiplex panels that capture a broader spectrum of inflammatory markers. Laboratory Corporation of America Holdings and Bio-Rad Laboratories Inc. focus on laboratory services and specialized reagent development, respectively. Exagen Inc. and Remission Medical differentiate through point-of-care inflammatory marker testing and patient-centric self-test solutions. Emerging players like Genway Biotech, Inc., Svar Life Sciences AB, Augurex Life Sciences Corporation, Arthritis Society Canada, and Apollo Health and Lifestyle Limited cultivate collaborative research partnerships, exploring bespoke biomarkers and clinical trial applications. These strategic initiatives exemplify how established corporations and agile start-ups jointly accelerate diagnostic innovation.

Actionable Recommendations for Industry Leadership

  • Prioritize integration of AI and automation in workflows to enhance diagnostic accuracy and reduce turnaround times.
  • Develop strategic supply chain partnerships to insulate operations against tariff-induced cost volatility and ensure reagent availability.
  • Foster cross-functional collaborations between R&D teams and clinical end users to refine biomarker panels and validate novel assay performance.
  • Implement region-specific market entry tactics, tailoring product portfolios to regulatory and reimbursement landscapes in Americas, EMEA, and Asia-Pacific.
  • Expand point-of-care and self-test kit offerings with user-friendly interfaces to capture emerging demand for decentralized testing.
  • Invest in digital platforms that aggregate diagnostic data, facilitate remote monitoring, and support real-world evidence generation for product adoption.

Conclusion: Navigating Future Opportunities

The evolving RA diagnostic market presents a landscape of both challenges and opportunities. Stakeholders must navigate tariff pressures, embrace technological breakthroughs, and adapt to region-specific regulatory frameworks to sustain growth. Robust segmentation strategies allow precise targeting of end users-from hospital laboratories to home-testing consumers-while corporate agility in supply chain management mitigates cost disruptions. Pioneering companies that integrate AI-driven analytics with multiplex assay designs will set the benchmark for diagnostic accuracy, whereas strategic alliances and public-private collaborations will accelerate biomarker discovery and clinical validation. By aligning product development with reimbursement incentives and patient needs, industry leaders can deliver tailored solutions that improve clinical outcomes and expand market reach. Ultimately, a cohesive approach that balances innovation, cost-effectiveness, and operational resilience will define success in the competitive RA diagnostics arena.

Market Segmentation & Coverage

This research report categorizes the Rheumatoid Arthritis Diagnosis Tests Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Blood Tests
    • Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test
    • C-Reactive Protein (CRP) Test
    • Erythrocyte Sedimentation Rate (ESR) Test
    • Rheumatoid Factor (RF) Test
  • Imaging Tests
    • MRI
    • Ultrasound
    • X-Ray
  • Physical Examination
    • Joint Flexibility Assessment
    • Swelling Analysis
  • Diagnostic Laboratories
    • Hospital-Based Labs
    • Independent Labs
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Research Institutions
    • Academic Research Institutes
    • Biotechnology Companies
  • Conventional Diagnostics
    • Point-of-Care Testing Devices
    • Standard Computing Measurement
  • Innovative Technology
    • Automation in Testing
    • Integration with Artificial Intelligence
  • Adult Segment
    • 18-30 Years
    • 31-50 Years
    • 51-70 Years
  • Pediatric Segment
    • 0-18 Years
  • Rapid Test Kits
    • Multi-Use Kits
    • Single Use Kits
  • Self-Test Kits
    • Home-Based Testing Kits
  • Clinical Diagnosis
    • Initial Diagnosis
    • Routine Follow-Up
  • Research and Development
    • Clinical Trials
    • Novel Biomarkers Exploration
  • Multiplex Tests
    • Panels for Multiple Biomarkers
  • Standard
    • Single Analyte Tests

This research report categorizes the Rheumatoid Arthritis Diagnosis Tests Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Rheumatoid Arthritis Diagnosis Tests Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • Apollo Health and Lifestyle Limited
  • Arthritis Society Canada
  • Augurex Life Sciences Corporation
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • Exagen Inc.
  • F. Hoffmann-La Roche AG
  • Genway Biotech, Inc.
  • Laboratory Corporation of America Holdings
  • QIAGEN GmbH
  • Remission Medical
  • Siemens Healthineers
  • Svar Life Sciences AB
  • Thermo Fisher Scientific, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Rheumatoid Arthritis Diagnosis Tests Market, by Test Type
8.1. Introduction
8.2. Blood Tests
8.2.1. Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test
8.2.2. C-Reactive Protein (CRP) Test
8.2.3. Erythrocyte Sedimentation Rate (ESR) Test
8.2.4. Rheumatoid Factor (RF) Test
8.3. Imaging Tests
8.3.1. MRI
8.3.2. Ultrasound
8.3.3. X-Ray
8.4. Physical Examination
8.4.1. Joint Flexibility Assessment
8.4.2. Swelling Analysis
9. Rheumatoid Arthritis Diagnosis Tests Market, by End User
9.1. Introduction
9.2. Diagnostic Laboratories
9.2.1. Hospital-Based Labs
9.2.2. Independent Labs
9.3. Hospitals
9.3.1. Private Hospitals
9.3.2. Public Hospitals
9.4. Research Institutions
9.4.1. Academic Research Institutes
9.4.2. Biotechnology Companies
10. Rheumatoid Arthritis Diagnosis Tests Market, by Technology
10.1. Introduction
10.2. Conventional Diagnostics
10.2.1. Point-of-Care Testing Devices
10.2.2. Standard Computing Measurement
10.3. Innovative Technology
10.3.1. Automation in Testing
10.3.2. Integration with Artificial Intelligence
11. Rheumatoid Arthritis Diagnosis Tests Market, by Age Group
11.1. Introduction
11.2. Adult Segment
11.2.1. 18-30 Years
11.2.2. 31-50 Years
11.2.3. 51-70 Years
11.3. Pediatric Segment
11.3.1. 0-18 Years
12. Rheumatoid Arthritis Diagnosis Tests Market, by Test Kits
12.1. Introduction
12.2. Rapid Test Kits
12.2.1. Multi-Use Kits
12.2.2. Single Use Kits
12.3. Self-Test Kits
12.3.1. Home-Based Testing Kits
13. Rheumatoid Arthritis Diagnosis Tests Market, by Application
13.1. Introduction
13.2. Clinical Diagnosis
13.2.1. Initial Diagnosis
13.2.2. Routine Follow-Up
13.3. Research and Development
13.3.1. Clinical Trials
13.3.2. Novel Biomarkers Exploration
14. Rheumatoid Arthritis Diagnosis Tests Market, by Design
14.1. Introduction
14.2. Multiplex Tests
14.2.1. Panels for Multiple Biomarkers
14.3. Standard
14.3.1. Single Analyte Tests
15. Americas Rheumatoid Arthritis Diagnosis Tests Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Rheumatoid Arthritis Diagnosis Tests Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Rheumatoid Arthritis Diagnosis Tests Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. Apollo Health and Lifestyle Limited
18.3.3. Arthritis Society Canada
18.3.4. Augurex Life Sciences Corporation
18.3.5. Beckman Coulter, Inc.
18.3.6. Bio-Rad Laboratories Inc.
18.3.7. Exagen Inc.
18.3.8. F. Hoffmann-La Roche AG
18.3.9. Genway Biotech, Inc.
18.3.10. Laboratory Corporation of America Holdings
18.3.11. QIAGEN GmbH
18.3.12. Remission Medical
18.3.13. Siemens Healthineers
18.3.14. Svar Life Sciences AB
18.3.15. Thermo Fisher Scientific, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET MULTI-CURRENCY
FIGURE 2. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET MULTI-LANGUAGE
FIGURE 3. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST KITS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST KITS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DESIGN, 2024 VS 2030 (%)
FIGURE 20. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DESIGN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY C-REACTIVE PROTEIN (CRP) TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ERYTHROCYTE SEDIMENTATION RATE (ESR) TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RHEUMATOID FACTOR (RF) TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PHYSICAL EXAMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY JOINT FLEXIBILITY ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SWELLING ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PHYSICAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITAL-BASED LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY POINT-OF-CARE TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STANDARD COMPUTING MEASUREMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INNOVATIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AUTOMATION IN TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INTEGRATION WITH ARTIFICIAL INTELLIGENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INNOVATIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ADULT SEGMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY 18-30 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY 31-50 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY 51-70 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ADULT SEGMENT, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PEDIATRIC SEGMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY 0-18 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PEDIATRIC SEGMENT, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MULTI-USE KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SINGLE USE KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RAPID TEST KITS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SELF-TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOME-BASED TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SELF-TEST KITS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INITIAL DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ROUTINE FOLLOW-UP, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY NOVEL BIOMARKERS EXPLORATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MULTIPLEX TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PANELS FOR MULTIPLE BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MULTIPLEX TESTS, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STANDARD, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SINGLE ANALYTE TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STANDARD, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PHYSICAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INNOVATIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ADULT SEGMENT, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PEDIATRIC SEGMENT, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RAPID TEST KITS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SELF-TEST KITS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MULTIPLEX TESTS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STANDARD, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PHYSICAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INNOVATIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ADULT SEGMENT, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PEDIATRIC SEGMENT, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RAPID TEST KITS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SELF-TEST KITS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MULTIPLEX TESTS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STANDARD, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PHYSICAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INNOVATIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ADULT SEGMENT, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PEDIATRIC SEGMENT, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RAPID TEST KITS, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SELF-TEST KITS, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MULTIPLEX TESTS, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STANDARD, 2018-2030 (USD MILLION)
TABLE 147. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 148. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 149. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 150. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PHYSICAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 151. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 153. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 154. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 155. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 157. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INNOVATIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 159. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ADULT SEGMENT, 2018-2030 (USD MILLION)
TABLE 160. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PEDIATRIC SEGMENT, 2018-2030 (USD MILLION)
TABLE 161. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
TABLE 162. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RAPID TEST KITS, 2018-2030 (USD MILLION)
TABLE 163. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SELF-TEST KITS, 2018-2030 (USD MILLION)
TABLE 164. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 166. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 167. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 168. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MULTIPLEX TESTS, 2018-2030 (USD MILLION)
TABLE 169. CANADA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STANDARD, 2018-2030 (USD MILLION)
TABLE 170. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 171. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 172. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 173. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PHYSICAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 174. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 176. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 177. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 178. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 180. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INNOVATIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 182. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ADULT SEGMENT, 2018-2030 (USD MILLION)
TABLE 183. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PEDIATRIC SEGMENT, 2018-2030 (USD MILLION)
TABLE 184. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
TABLE 185. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RAPID TEST KITS, 2018-2030 (USD MILLION)
TABLE 186. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SELF-TEST KITS, 2018-2030 (USD MILLION)
TABLE 187. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 189. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 190. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 191. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MULTIPLEX TESTS, 2018-2030 (USD MILLION)
TABLE 192. MEXICO RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STANDARD, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PHYSICAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INNOVATIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ADULT SEGMENT, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PEDIATRIC SEGMENT, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RAPID TEST KITS, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SELF-TEST KITS, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MULTIPLEX TESTS, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STANDARD, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PHYSICAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INNOVATIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ADULT SEGMENT, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PEDIATRIC SEGMENT, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RAPID TEST KITS, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SELF-TEST KITS, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MULTIPLEX TESTS, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STANDARD, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 241. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PHYSICAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INNOVATIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ADULT SEGMENT, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PEDIATRIC SEGMENT, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RAPID TEST KITS, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SELF-TEST KITS, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MULTIPLEX TESTS, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY STANDARD, 2018-2030 (USD MILLION)
TABLE 264. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 265. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 266. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 267. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PHYSICAL EXAMINATION, 2018-2030 (USD MILLION)
TABLE 268. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 270. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 271. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 272. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CONVENTIONAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 274. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY INNOVATIVE TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 276. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY ADULT SEGMENT, 2018-2030 (USD MILLION)
TABLE 277. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY PEDIATRIC SEGMENT, 2018-2030 (USD MILLION)
TABLE 278. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY TEST KITS, 2018-2030 (USD MILLION)
TABLE 279. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RAPID TEST KITS, 2018-2030 (USD MILLION)
TABLE 280. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY SELF-TEST KITS, 2018-2030 (USD MILLION)
TABLE 281. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 283. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 284. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
TABLE 285. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS TESTS MARKET SIZE, BY MULTIPLEX TESTS, 2018-2030 (USD MILLION)
TABLE 286. CHINA RHEUMATOID ARTHRITIS DIAGNOSIS

Companies Mentioned

  • Abbott Laboratories
  • Apollo Health and Lifestyle Limited
  • Arthritis Society Canada
  • Augurex Life Sciences Corporation
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • Exagen Inc.
  • F. Hoffmann-La Roche AG
  • Genway Biotech, Inc.
  • Laboratory Corporation of America Holdings
  • QIAGEN GmbH
  • Remission Medical
  • Siemens Healthineers
  • Svar Life Sciences AB
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Rheumatoid Arthritis Diagnosis Tests - Global Strategic Business Report - Product Image

Rheumatoid Arthritis Diagnosis Tests - Global Strategic Business Report

  • Report
  • 441 Pages
  • Global
From
Rheumatoid Arthritis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Rheumatoid Arthritis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 211 Pages
  • Global
From
Rheumatoid Arthritis Diagnostic Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Rheumatoid Arthritis Diagnostic Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 184 Pages
  • Global
From
United States Autoimmune Disease Diagnostics Market, By Region, Competition, Forecast and Opportunities, 2019-2029F - Product Image

United States Autoimmune Disease Diagnostics Market, By Region, Competition, Forecast and Opportunities, 2019-2029F

  • Report
  • 83 Pages
  • United States
From
Rheumatoid Arthritis - Pipeline Insight, 2025 - Product Image

Rheumatoid Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • 180 Pages
  • Global
From

About the Rheumatoid Arthritis Test Market

The Rheumatoid Arthritis Test market within the In Vitro Diagnostics sector is a rapidly growing segment. It is used to diagnose and monitor the progression of the autoimmune disorder, Rheumatoid Arthritis. Tests are used to detect the presence of autoantibodies in the blood, which are associated with the disease. The tests are used to diagnose the disease, as well as to monitor the effectiveness of treatments. The market is driven by the increasing prevalence of Rheumatoid Arthritis, as well as the development of new technologies and tests. The market is also driven by the increasing demand for early diagnosis and treatment of the disease. Some of the major players in the Rheumatoid Arthritis Test market include Abbott Laboratories, Bio-Rad Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.